Streetbeat News

Revenues

BLDR

Builders FirstSource (NYSE:BLDR) received diverse analyst ratings over the past quarter, with a shift towards more neutral positions in the last 30 days. The average 12-month price target for BLDR is now $215.43, marking a 12.79% increase from the previous target of $191.00. Analysts from firms like DA Davidson, Barclays, and RBC Capital have updated their ratings and price targets, reflecting changes in market conditions and company performance. Despite a negative revenue trend and challenges in maintaining profitability, BLDR's strong ROE and ROA indicate effective capital utilization. The company's market capitalization and debt management are also highlighted as strengths.

Portfolio Pulse from Benzinga Insights

March 28, 2024 | 4:00 pm

ZION

Zions Bancorp (NASDAQ:ZION) has seen varied analyst ratings over the last three months, with a recent shift towards more positive evaluations. The average 12-month price target has increased to $46.00, reflecting a 6.98% rise from the previous target. Analyst actions include both upgrades and downgrades, with price targets ranging from $40.00 to $48.00. Zions Bancorp, a regional U.S. bank, faces challenges in market capitalization, revenue growth, and net margin, but excels in ROE while maintaining a low debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

March 28, 2024 | 4:00 pm

SHWZ

Schwazze (OTC:SHWZ) reported a revenue increase of 8% in Q4 2023 to $43.3 million, despite a challenging competitive landscape in the cannabis retail sector, particularly in Colorado and New Mexico. The company expanded its store footprint by over 50% to 63 dispensaries. However, gross profit dropped significantly to $7.0 million from $21.7 million in the same quarter last year, leading to a net loss of $33.9 million. The company attributes the fierce competition and market pressures for the financial outcomes but remains optimistic about future growth and regulatory momentum.

Portfolio Pulse from Maureen Meehan

March 28, 2024 | 3:42 pm

LH

OPK

Laboratory Corporation Of America Holdings (NYSE:LH) has acquired select operations of Opko Health, Inc's (NASDAQ:OPK) subsidiary BioReference Health. The deal, valued at $237.5 million, involves assets generating about $100 million in annual revenue. This acquisition aims to expand Labcorp's diagnostic services reach, excluding New York and New Jersey, and is expected to enhance patient and physician experiences by providing broader access to Labcorp's laboratory services and testing capabilities. OPK shares rose 12.14% to $1.20 following the announcement.

Portfolio Pulse from Akanksha Bakshi

March 28, 2024 | 3:41 pm

LOWLF

Lowell Farms Inc (OTCQB:LOWLF), a California-based cannabis company, reported a 35% decrease in annual revenue for 2023, totaling $28.3 million, and a 19% decrease in Q4 revenue to $7.5 million. The company experienced a net loss of $37.3 million for the year and $13.1 million for Q4. Despite these challenges, Lowell Farms is optimistic about its restructuring and strategic realignments aimed at improving its operational framework and financial health.

Portfolio Pulse from Patricio Liddle

March 28, 2024 | 3:26 pm

WB

Weibo Corp (NASDAQ:WB) experienced a softer than expected recovery in advertising revenues in 2023, leading to a downgrade by Goldman Sachs from Buy to Neutral and a reduction in price target from US$17.10 to US$10.60. The downgrade is attributed to weaker household consumption, stiff content competition, and structural wallet share loss to SFVs. Higher investments in vertical content are expected to pressure sales and margins in 2024, with ad revenue growth projected at 3-4% yoy in 2024 or 3% CAGR in 2023-26. Shares of Weibo declined by 1.79% to $9.33.

Portfolio Pulse from Priya Nigam

March 28, 2024 | 3:20 pm

CMCL

Caledonia Mining (AMEX:CMCL) reported a significant decrease in Q4 adjusted earnings per share to $0.02, down from $0.41 YoY, despite a 13.12% increase in sales to $38.66M from $34.18M YoY.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 3:13 pm

REBN

Reborn Coffee (NASDAQ:REBN) reported a Q4 EPS loss of $(0.56), an improvement from $(0.72) YoY. Sales increased to $1.80M from $860.65K YoY, marking a 108.91% increase.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 3:12 pm

HBAN

Huntington Bancshares (NASDAQ:HBAN) has been analyzed by 8 analysts, showing a mix of bullish to bearish sentiments. Recent ratings adjustments and price target changes reflect a positive outlook, with an average 12-month price target of $15.19, up 15.16% from the previous target. The company faces challenges with a revenue decline of -9.33% and below-average profitability metrics. Analysts' updates suggest optimism, despite financial performance concerns.

Portfolio Pulse from Benzinga Insights

March 28, 2024 | 3:01 pm

MTB

M&T Bank (NYSE:MTB) received mixed analyst ratings with a recent average price target of $162.29, up 4.7% from the previous target. The bank's financial performance shows a revenue decline of -2.69% but outperforms in ROE and ROA, despite a high debt-to-equity ratio. Analysts' actions vary, with some raising and others maintaining or lowering their ratings and price targets.

Portfolio Pulse from Benzinga Insights

March 28, 2024 | 3:00 pm